IMMUTEP LTD ORDINARY (IMM) Short Interest
IMMUTEP LTD ORDINARY (ASX:IMM) had 2.59% of shares reported as short positions as of 26 June 2026, representing 38,152,096 shares. IMMUTEP LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
IMM
Immutep
Pharmaceuticals, Biotechnology & Life Sciences
Immutep is a biotechnology company focused on developing LAG-3 related immunotherapy products for the treatment of cancer and autoimmune diseases. The company is pioneering the LAG-3 space and has clinical-stage assets targeting areas of high unmet need.
biotechnology
pharmaceuticals
immunotherapy
oncology
Shorted
short percentage2.59%
reported shorts38.2M
shares on issue1.474B